Job Opportunities
A number of faculty in the Yale Stem Cell Center are recruiting for postdoctoral positions in stem cell biology.
Yale is an affirmative action/equal opportunity employer.
Position in the laboratory of Dr. Andrew Xiao
A newly established laboratory of Andrew Xiao , Ph.D., Yale Stem Cell Center, Department of Genetics at Yale University School of Medicine is inviting applications for multiple postdoctoral positions. With an emphasis on chromatin biology, the lab focuses on investigating molecular mechanisms for mammalian stem cell biology, cellular reprogramming (iPS) and embryonic development.
Position in the laboratory of Dr. Craig Crews
The lab of Craig Crews, Ph.D., Department of Molecular, Cellular and Developmental Biology at Yale is inviting applications for multiple postdoctoral positions. With an emphasis on regenerative medicine, the lab investigates the inductive role of the wound epidermis on cellular dedifferentiation during amphibian limb regeneration.
Positions in the laboratory of Dr. Diane Krause
The laboratory of Diane Krause M.D. Ph.D., Associate Director of the Yale Stem Cell Center, and Professor of Laboratory Medicine at Yale University School of Medicine, has 3 open postdoctoral positions.
Postdoctoral Position in Retinal Stem Cell Research
A position is available Sept. 1, 2010 to study the development of the outer retina using human embryonic stem cells. During differentiation, the retinal pigment epithelium (RPE) matures in response to the differentiation of retinal neurons. To study this process, we are engineering a three-dimensional culture model of the outer retina.
Position in the laboratory of Dr. Natalia Ivanova
A wide variety of projects are available to define mechanisms of cell fate determination in mouse and human embryonic stem cells using both traditional and genomic approaches. Applicants should have training and experience in molecular biology and mammalian cell culture techniques.
Position in the laboratory of Dr. Yibing Qyang
A postdoctoral position is available in the area of cardiovascular (CV) stem cell biology. We are striving to ameliorate heart diseases utilizing a novel population of CV stem cells, coupled with embryonic stem cells, high-throughput chemical screening and tissue engineering.
